Efficacy and safety of a single‐tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV‐1‐infected subjects on nonnucleoside reverse transcriptase inhibitor‐containing first‐line antiretroviral therapy in Pune, India

OBJECTIVES: As per National AIDS Control Organization (NACO) estimates, there are 2.1 million people living with HIV (PWH) in India, of whom 1.2 million are on first‐line antiretroviral therapy (ART). This study explored the use of a single‐tablet regimen containing tenofovir disoproxil fumarate 300...

Descripción completa

Detalles Bibliográficos
Autores principales: Dravid, A, Betha, TP, Sharma, AK, Gawali, R, Mahajan, U, Kulkarni, M, Saraf, C, Kore, S, Dravid, M, Rathod, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539943/
https://www.ncbi.nlm.nih.gov/pubmed/33021066
http://dx.doi.org/10.1111/hiv.12912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539943/
https://www.ncbi.nlm.nih.gov/pubmed/33021066
http://dx.doi.org/10.1111/hiv.12912

Ejemplares similares